Product Code: 978-1-68038-969-2
Protein Labeling Market Growth & Trends:
The global protein labeling market size is expected to reach USD 4.27 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.46% from 2024 to 2030. The study of Post-translational Modification (PTM) of proteins has gained immense popularity in cell biology and disease treatment and prevention. The introduction of effective quantification methods of protein expression with the use of tagging strategies, such as iodoTMTzero Label Reagent that detects nitrosylation, has driven an efficient determination of PTMs. Therefore, a rise in PTM-related studies is driving the market. The emergence of novel techniques and the launch of improved products are expected to positively influence market growth.
One such development includes the application of new spin labels that expand the capability of site-directed spin labeling of proteins. These labels in combination with electron paramagnetic resonance spectroscopy (SDSL-EPR) enable the investigation of protein structure, dynamics, and structural heterogeneity. The market is growing as private players and government agencies increased investments in proteomics and genomics R&D. Proteomics is the study of the entire protein content of a cell, tissue, or organism. Proteomic profiling approaches require protein labeling methods before separation and analysis. For example, the United States National Institutes of Health (NIH) allocated USD 37 billion to scientific research.
Moreover, there is an increase in funding for life sciences research that supports molecular studies to better understand the fundamental processes by which diseases emerge, as well as the identification of biomarkers that identify the presence of disease or the gene/protein responsible for the condition. The Novo Nordisk Foundation awarded the University of Copenhagen a grant of up to USD 1.5 million to create a mass spectrometry facility, which is a new and exciting step in protein research. As a result, the market is being driven by increased spending on proteomics and genomics research and development. Protein labeling applications are widely employed for a variety of functions. Cell-based assays can offer information about intracellular molecular targets and have the advantage of being performed in a biological context.
Fluorescent antibodies are important in clinical therapy as well as for investigating immunology, cell biology, and neuroscience. A mass spectrometer is a device that detects the m/z ratio of ions to identify and quantify compounds in simple and complicated mixtures. It has proven indispensable in a variety of domains and applications, including proteomics. Immunological approaches include ways of studying the immune system as well as the application of immunological reagents as instruments. Protein microarrays are a new type of proteomic technology that is rapidly gaining popularity in molecular biology and biochemistry.
Protein Labeling Market Report Highlights:
- Proteins dominated the reagents segment in 2023 as fluorescent proteins are beneficial and allow in situ fusion expression through gene transfer into cells
- This eliminates the need for purification, in vitro labeling, high-level heterologous production, and microinjection of recombinant proteins
- The fluorescence microscopy segment is estimated to register the fastest CAGR from 2024 to 2030 due to the development of monomeric fluorescent proteins that are capable to fluoresce orange to far-red bands of the visible light spectrum
- The in-vitro labeling segment accounted for the largest revenue share in 2023 and is anticipated to witness the fastest CAGR during the forecast period
- The less complexity associated with in-vitro techniques and the availability of a large number of commercial kits for these techniques result in a larger share of the segment in 2023
- North America accounted for the maximum revenue share in 2023 due to the presence of key manufacturers, increase in proteomics research, the advent of bioengineering technologies, and high adoption of these products in disease diagnosis-associated studies
Table of Contents
Chapter 1. Protein Labeling Market: Methodology and Scope
- 1.1. Information Procurement
- 1.2. Information Or Data Analysis
- 1.3. Market Scope & Segment Definition
- 1.4. Market Model
- 1.4.1. Market Study, By Company Market Share
- 1.4.2. Regional Analysis
Chapter 2. Protein Labeling Market: Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Protein Labeling Market: Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increase In R&D Spending Pertaining To Proteomics Research
- 3.2.1.2. Increase In Adoption Of Bioengineering Techniques
- 3.2.1.3. Increase In Technological Advancements In The Market
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Lack Of Skilled Professionals
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis
Chapter 4. Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Global Protein Labeling Market Product Movement Analysis
- 4.3. Global Protein Labeling Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Reagents
- 4.4.1. Reagents market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2. Proteins
- 4.4.2.1. Proteins market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.3. Enzymes
- 4.4.3.1. Enzymes market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.4. Probes/Tags
- 4.4.4.1. Probes/tags estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.5. Monoclonal Antibodies
- 4.4.5.1. Monoclonal antibodies market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.6. Other Reagents
- 4.4.6.1. Other reagents market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5. Kits
- 4.5.1. Kits market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6. Services
- 4.6.1. Services market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Protein Labeling Market: Method Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Global Protein Labeling Market Method Movement Analysis
- 5.3. Global Protein Labeling Market Size & Trend Analysis, by Method, 2018 to 2030 (USD Million)
- 5.4. In-vitro Labeling Methods
- 5.4.1. In-vitro labeling methods market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2. Enzymatic Labeling
- 5.4.2.1. Enzymatic labeling market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.3. Dye-based Labeling
- 5.4.3.1. Dye-based labeling market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.4. Co-translational Labeling
- 5.4.4.1. Co-translational labeling market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.5. Site-specific Labeling
- 5.4.5.1. Site-specific labeling market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.6. Nanoparticle Labeling
- 5.4.6.1. Nanoparticle labeling market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.7. Others
- 5.4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Protein Labeling Market: Application Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Global Protein Labeling Market Application Movement Analysis
- 6.3. Global Protein Labeling Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 6.4. Immunological Techniques
- 6.4.1. Immunological Techniques market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5. Cell-based Arrays
- 6.5.1. Cell-based arrays market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6. Fluorescence Microscopy
- 6.6.1. Fluorescence microscopy arrays market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7. Protein Microarray
- 6.7.1. Protein microarray market estimates and forecasts 2018 to 2030 (USD Million)
- 6.8. Mass Spectrometry
- 6.8.1. Mass spectrometry market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Epigenetics Market: Regional Estimates & Trend Analysis
- 7.1. Regional Market Share Analysis, 2023 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 7.4. North America
- 7.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.2. U.S.
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Competitive scenario
- 7.4.2.3. Regulatory framework
- 7.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.3. Canada
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Competitive scenario
- 7.4.3.3. Regulatory framework
- 7.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.4. Mexico
- 7.4.4.1. Key country dynamics
- 7.4.4.2. Competitive scenario
- 7.4.4.3. Regulatory framework
- 7.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5. Europe
- 7.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.2. UK
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Competitive scenario
- 7.5.2.3. Regulatory framework
- 7.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.3. Germany
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Competitive scenario
- 7.5.3.3. Regulatory framework
- 7.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.4. France
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Competitive scenario
- 7.5.4.3. Regulatory framework
- 7.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.5. Italy
- 7.5.5.1. Key country dynamics
- 7.5.5.2. Competitive scenario
- 7.5.5.3. Regulatory framework
- 7.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.6. Spain
- 7.5.6.1. Key country dynamics
- 7.5.6.2. Competitive scenario
- 7.5.6.3. Regulatory framework
- 7.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.7. Norway
- 7.5.7.1. Key country dynamics
- 7.5.7.2. Competitive scenario
- 7.5.7.3. Regulatory framework
- 7.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.8. Sweden
- 7.5.8.1. Key country dynamics
- 7.5.8.2. Competitive scenario
- 7.5.8.3. Regulatory framework
- 7.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.9. Denmark
- 7.5.9.1. Key country dynamics
- 7.5.9.2. Competitive scenario
- 7.5.9.3. Regulatory framework
- 7.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6. Asia Pacific
- 7.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.2. Japan
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Competitive scenario
- 7.6.2.3. Regulatory framework
- 7.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.3. China
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Competitive scenario
- 7.6.3.3. Regulatory framework
- 7.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.4. India
- 7.6.4.1. Key country dynamics
- 7.6.4.2. Competitive scenario
- 7.6.4.3. Regulatory framework
- 7.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.5. Australia
- 7.6.5.1. Key country dynamics
- 7.6.5.2. Competitive scenario
- 7.6.5.3. Regulatory framework
- 7.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.6. South Korea
- 7.6.6.1. Key country dynamics
- 7.6.6.2. Competitive scenario
- 7.6.6.3. Regulatory framework
- 7.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.7. Thailand
- 7.6.7.1. Key country dynamics
- 7.6.7.2. Competitive scenario
- 7.6.7.3. Regulatory framework
- 7.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7. Latin America
- 7.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.2. Brazil
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Competitive scenario
- 7.7.2.3. Regulatory framework
- 7.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.3. Argentina
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Competitive scenario
- 7.7.3.3. Regulatory framework
- 7.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8. MEA
- 7.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.2. South Africa
- 7.8.2.1. Key country dynamics
- 7.8.2.2. Competitive scenario
- 7.8.2.3. Regulatory framework
- 7.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.3. Saudi Arabia
- 7.8.3.1. Key country dynamics
- 7.8.3.2. Competitive scenario
- 7.8.3.3. Regulatory framework
- 7.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.4. UAE
- 7.8.4.1. Key country dynamics
- 7.8.4.2. Competitive scenario
- 7.8.4.3. Regulatory framework
- 7.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.5. Kuwait
- 7.8.5.1. Key country dynamics
- 7.8.5.2. Competitive scenario
- 7.8.5.3. Regulatory framework
- 7.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Company/Competition Categorization
- 8.2. Strategy Mapping
- 8.3. Company Market Position Analysis, 2023
- 8.4. Company Profiles/Listing
- 8.4.1. Thermo Fisher Scientific Inc.
- 8.4.1.1. Company overview
- 8.4.1.2. Financial performance
- 8.4.1.3. Product benchmarking
- 8.4.1.4. Strategic initiatives
- 8.4.2. Merck KGaA
- 8.4.2.1. Company overview
- 8.4.2.2. Financial performance
- 8.4.2.3. Product benchmarking
- 8.4.2.4. Strategic initiatives
- 8.4.3. Revvity Inc. (PerkinElmer, Inc.)
- 8.4.3.1. Company overview
- 8.4.3.2. Financial performance
- 8.4.3.3. Product benchmarking
- 8.4.3.4. Strategic initiatives
- 8.4.4. Promega Corporation
- 8.4.4.1. Company overview
- 8.4.4.2. Financial performance
- 8.4.4.3. Product benchmarking
- 8.4.4.4. Strategic initiatives
- 8.4.5. F. Hoffmann-La Roche Ltd.
- 8.4.5.1. Company overview
- 8.4.5.2. Financial performance
- 8.4.5.3. Product benchmarking
- 8.4.5.4. Strategic initiatives
- 8.4.6. LGC Limited
- 8.4.6.1. Company overview
- 8.4.6.2. Financial performance
- 8.4.6.3. Product benchmarking
- 8.4.6.4. Strategic initiatives
- 8.4.7. New England Biolabs
- 8.4.7.1. Company overview
- 8.4.7.2. Financial performance
- 8.4.7.3. Product benchmarking
- 8.4.7.4. Strategic initiatives
- 8.4.8. LI-COR, Inc.
- 8.4.8.1. Company overview
- 8.4.8.2. Financial performance
- 8.4.8.3. Product benchmarking
- 8.4.8.4. Strategic initiatives
- 8.4.9. Danaher
- 8.4.9.1. Company overview
- 8.4.9.2. Financial performance
- 8.4.9.3. Product benchmarking
- 8.4.9.4. Strategic initiatives
- 8.4.10. Jena Bioscience GmbH
- 8.4.10.1. Company overview
- 8.4.10.2. Financial performance
- 8.4.10.3. Product benchmarking
- 8.4.10.4. Strategic initiatives